SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

A sharp selloff without a confirmed company-specific update is driving discussion, with traders pointing to options expiration, biotech-sector weakness and possible short-term trading pressure. The drop has stirred frustration and concern about SELLASs prolonged silence on the REGAL Phase 3 trial, while bullish holders view it as volatility ahead of the anticipated event update or topline results and are buying the dip.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas Roadster demonstration featuring SpaceX-linked thrusters is driving discussion, with some traders impressed by the engineering and speculating about closer TeslaSpaceX ties. Skeptics argue the long-delayed, low-volume vehicle has little near-term earnings potential and question whether the technology is practical or will reach production as shown.

SK hynix, Inc. engages in the design, manufacture, and sale of semiconductor products. Its products include dynamic random access memory, not-AND flash memory, and multi-chip package. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is caught in a sharp memory and semiconductor selloff, with traders pointing to weak Korean-market flows and concerns about AI investment returns and financing; reports of progress by Chinas CXMT are adding to competition worries. Bulls argue the decline is overdone given HBM demand and valuation, while bears see memory-cycle normalization and continued downside risk.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas sharp pullback after a steep rally has traders debating profit-taking and valuation, with some also pointing to insider share sales; bulls view the decline as a dip while bears warn the run may be overextended. The main focus remains the upcoming full Phase 3 melanoma cancer-vaccine data, which traders see as a potential catalyst but also a risk for a sell-the-news reaction.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is drawing attention amid a sharp semiconductor and AI-stock selloff, with traders citing concerns about AI spending and valuations, inflation and weakness in Korean chip stocks; its 3x leverage magnifies the moves. The community is split between treating the decline as an oversold dip for a possible rebound and expecting further losses.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Concerns over CoreWeaves debt-funded AI infrastructure expansion and rising borrowing costs are driving the discussion, with some traders also pointing to founder share sales as a warning sign. Bulls cite Nvidia CEO Jensen Huangs reassurance and analyst support as reasons for the sharp rebound, while bears argue that financing and refinancing risks remain unresolved.

Robinhood GLD is a tokenized representation of SPDR Gold Shares (GLD) common stock, issued on Robinhood Chain, Robinhood's own blockchain built to bring tokenized real-world assets on-chain. Each token is designed to track the price of the underlying GLD share, giving holders on-chain price exposure to SPDR Gold Shares's stock. The token is freely transferable and composable across the Robinhood Chain ecosystem. It's part of Robinhood's broader initiative to expand access to tokenized U.S. equities via blockchain technology, alongside a wider lineup of tokenized stock tokens launching on the same network.

GoldCoin

Golds pullback and rebound amid changing U.S. Treasury yields, dollar strength, and Fed rate-hike expectations dominate discussion. Traders are split between buying the dip and warning that elevated yields and a stronger dollar could keep pressure on gold.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Goldman Sachs upgrade to Buy, alongside a wave of analyst price-target increases following Zeta Lives AI and partnership announcements, has fueled attention and a move to a 52-week high. Traders are largely bullish ahead of earnings, while debating whether the pullback reflects profit-taking and options-expiration positioning or a pause after a sharp run-up.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

RGC is drawing attention as traders speculate that its history of extreme meme-stock runs, concentrated insider ownership and claims of limited short availability could set up another sharp squeeze if buying volume returns. Others warn the move is hype-driven and point to the stocks volatility and company risks, leaving bullish squeeze bets at odds with pump-and-dump concerns.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

NOW is drawing attention for volatile swings and repeated failed breakouts, with traders debating whether analyst upgrades and enterprise-AI optimism can overcome selling pressure. Recent weakness is largely viewed as part of a broader software-sector selloff, with concerns about AI disruption competing against the bullish view that ServiceNow can monetize AI workflows.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS is down over 10% today but is still up over 125% year-to-date. Are you buying the dip?

SELLAS Life Sciences ($SLS) is down over 10% today and well off its 52-week high of $15.88, as investors wait on final analysis of its Phase 3 REGAL trial in AML and Phase 2 data for SLS009 expected in the fourth quarter. Are you buying $SLS on the dip? Vote and explain your reasoning in the comments.

Jesse101

EasyLode

상후니

Daffy

Jeff

Charles ford

Stephen

Ulaughing

Drill_baby_drill_

Stocktwits

 is down over 10% today but is still up over 125% year-to-date. Are you buying the dip?

Stocktwits Polls

Tim Welicky

StockTwits Web

Possibly Professional Trader

@StocktwitsPolls wow $SLS got it’s very own poll

StockTwits for iOS

Frank

@StocktwitsPolls picked up nine more shares.

Hello There

@StocktwitsPolls obviously a raid so they don’t have to pay options at $11 and maybe even $10. We NEED some news

 obviously a raid so they don’t have to pay options at $11 and maybe even $10. We NEED some news

mmdwacjm

@StocktwitsPolls  Bought some more. First, SLS is a 2 asset AML company, and nothing about the science or the probability of  successful data readouts has changed. What happened this morning is due to REGAL fatigue(some retail gets tired of  waiting), short sellers, options expirations. Typical ebb and flow that makes a few shekels for the day trader, but as an investor will adhere to my Buffetinian mode. Its Turtles that win races.

  Bought some more. First, SLS is a 2 asset AML company, and nothing about the science or the probability of  successful data readouts has changed. What happened this morning is due to REGAL fatigue(some retail gets tired of  waiting), short sellers, options expirations. Typical ebb and flow that makes a few shekels for the day trader, but as an investor will adhere to my Buffetinian mode. Its Turtles that win races.